Search research articles
Contact Us
Filters
Showing results (561-570 of 759) with videos related to
Page
of 76
Sort By:
Leukemia & Lymphoma
|
November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin
Jeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Leukemia & Lymphoma
|
July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysis
Abdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Bone Marrow Transplantation
|
August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
M Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 6, 2025
Comparative performance of <sup>99m</sup>Tc-pyrophosphate vs. <sup>99m</sup>Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging
Gregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Blood Advances
|
March 2, 2022
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
Charalampos Charalampous, Utkarsh Goel, Stephen M Broski, et al.
Leukemia
|
February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients
Alissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology
|
June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
Maximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Blood Cancer Journal
|
March 27, 2024
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Page
of 76
Search research articles
Search
Showing results (561-570 of 759) with videos related to
Sort By:
Page
of 76
Leukemia & Lymphoma
|
November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin
Jeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Leukemia & Lymphoma
|
July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysis
Abdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Bone Marrow Transplantation
|
August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
M Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 6, 2025
Comparative performance of <sup>99m</sup>Tc-pyrophosphate vs. <sup>99m</sup>Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging
Gregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Blood Advances
|
March 2, 2022
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
Charalampos Charalampous, Utkarsh Goel, Stephen M Broski, et al.
Leukemia
|
February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients
Alissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology
|
June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
Maximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Blood Cancer Journal
|
March 27, 2024
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
Page
of 76